With approximately one third of all current FDA-approved drugs targeting GPCRs ... and the latest data bodes well for future development of therapeutic options in these areas.
In recent years, even with remarkable scientific advancements and a significant increase of global research and development spending, drugs are frequently withdrawn from markets. This is primarily ...
Researchers at the University of Oklahoma have developed a breakthrough method of adding a single nitrogen atom to molecules, unlocking new possibilities in drug research and development.